Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI eye on the brain: a smarter scan for multiple sclerosis?

NCT ID NCT07111637

Recruiting now Diagnosis Sponsor: Queen Mary University of London Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This trial tests whether an AI tool called icobrain ms can help radiologists detect signs of multiple sclerosis (MS) activity on brain MRI scans. The study involves over 1,300 people with MS or early signs of it, who are already on treatment. The AI analyzes scans and creates structured reports, which may make it easier for doctors to see new or growing lesions and decide if a treatment change is needed. The goal is to see if this technology improves the accuracy and efficiency of MRI reading in the NHS.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI software called icobrain ms that analyzes MRI brain scans and generates reports for doctors
What this could lead to
If it works, this AI tool could help doctors detect MS activity more accurately and make better treatment decisions, potentially improving care for many people with MS.
What could go wrong
The AI may not perform consistently across different NHS settings, and its benefit over standard visual reading is still being tested. There is also a risk of over-reliance on automated reports.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

  • Barts Health NHS Trust

    RECRUITING

    London, E1 4NS, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.